Subsequently, we used immunohistochemical methods to detect HCP5‐132aa expression in 80 pairs of GC and adjacent tissues and associated these with follow‐up survival data to investigate the clinical relevance of the aberrantly high expression of HCP5‐132aa in GC. Here, HCP5 is linked to gastric cancer.